Last update 20 Jun 2024
PM-1022
Last update 20 Jun 2024
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms PM 1022, PM-1022 |
Target |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors), TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Related
2
Clinical Trials associated with PM-1022评价PM1022注射液在晚期肿瘤患者中的耐受性、安全性、药代动力学特征和初步疗效的 I 期临床试验及在晚期肿瘤患者中考察初步疗效的 IIa 期临床试验
[Translation] Phase I clinical trial to evaluate the tolerability, safety, pharmacokinetic characteristics and preliminary efficacy of PM1022 injection in patients with advanced tumors and Phase IIa clinical trial to examine the preliminary efficacy in patients with advanced tumors
A Phase I/IIa Study to Evaluate the Tolerance, Safety, Pharmacokinetic Characteristics and Preliminary Efficacy of PM1022 in Patients With Advanced Tumors
100 Clinical Results associated with PM-1022
Login to view more data
100 Translational Medicine associated with PM-1022
Login to view more data
100 Patents (Medical) associated with PM-1022
Login to view more data
100 Deals associated with PM-1022
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 2 | CN | 11 Apr 2022 | |
| Advanced cancer | Phase 1 | CN | 21 Jun 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1/2 | 15 | whjenrqfjm(oyuefzwvmf) = 20% koblockfla (vruqayerpp ) View more | Positive | 24 May 2024 | |||
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free